Valiant Laboratories Limited (VALIANTLAB.NS)
INR 128.1
(14.76%)
INR 128.1
(14.76%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 1.82 Billion | 3.33 Billion | 2.91 Billion | 1.82 Billion |
| Cost of Revenue | 1.68 Billion | 2.77 Billion | 2.39 Billion | 1.23 Billion |
| Gross Profit | 138.02 Million | 565.9 Million | 523.21 Million | 583.9 Million |
| Operating Expenses | 138.02 Million | 230.62 Million | 123.16 Million | 109.95 Million |
| Selling, General and Administrative Expenses | - | 24.46 Million | 17.45 Million | 11.84 Million |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | 138.02 Million | 48.62 Million | 4.62 Million | 330 Thousand |
| Cost and Expenses | 1.82 Billion | 3 Billion | 2.51 Billion | 1.34 Billion |
| Operating Income | - | 383.9 Million | 418.74 Million | 488.07 Million |
| Interest Expense | 778 Thousand | 2.53 Million | 730 Thousand | 17.84 Million |
| Income Tax Expense | -10.89 Million | 91.38 Million | 142.08 Million | 164.3 Million |
| Earnings before Tax | -7.69 Million | 381.36 Million | 417.04 Million | 470.23 Million |
| Net Income | 3.19 Million | 289.98 Million | 274.96 Million | 305.93 Million |
| Earnings Per Share Basic | 0.08 | 6.67 | 6.33 | 7.04 |
| Earnings Per Share Diluted | 0.08 | 6.67 | 6.33 | 7.04 |
| Weighted Average Shares Outstanding | 38 Million | 43.45 Million | 43.45 Million | 43.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 38 Million | 43.45 Million | 43.45 Million | 43.45 Million |
| Gross Margin | 0.08 | 0.17 | 0.18 | 0.32 |
| EBIT Margin | 0.01 | 0.12 | 0.15 | 0.28 |
| Profit Margin | 0.00 | 0.09 | 0.09 | 0.17 |
| EBITDA | 12.73 Million | 399.53 Million | 442.67 Million | 514.14 Million |
| Earnings Before Tax Margin | - | 0.11 | 0.14 | 0.27 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 188.84 Million | 305.87 Million | 1.82 Billion | 405.15 Million | 595.46 Million | 514.07 Million |
| Cost of Revenue | 190.01 Million | 300.02 Million | 1.68 Billion | 411.3 Million | 548.14 Million | 423.06 Million |
| Gross Profit | -1.17 Million | 5.84 Million | 138.02 Million | -6.14 Million | 47.32 Million | 91.01 Million |
| Operating Expenses | 28.06 Million | 56.34 Million | 241.76 Million | 61.86 Million | 66.08 Million | 57.47 Million |
| Selling, General and Administrative Expenses | 9.59 Million | 12.6 Million | - | 12.07 Million | 10.4 Million | 8.05 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 28.13 Million | 25.02 Million | 96.81 Million | 17.75 Million | 29.59 Million | 24.44 Million |
| Cost and Expenses | 218.07 Million | 356.36 Million | 1.92 Billion | 473.16 Million | 614.22 Million | 480.54 Million |
| Operating Income | -29.23 Million | -25.46 Million | -6.91 Million | -50.25 Million | 10.83 Million | 57.97 Million |
| Interest Expense | 529 Thousand | 207 Thousand | 778 Thousand | 187 Thousand | 191 Thousand | 193 Thousand |
| Income Tax Expense | 3.47 Million | -13.28 Million | -10.89 Million | -15.41 Million | 2.7 Million | 15.09 Million |
| Earnings before Tax | -1.62 Million | -25.67 Million | -7.69 Million | -50.44 Million | 10.63 Million | 57.78 Million |
| Net Income | -5.09 Million | -12.39 Million | 3.19 Million | -35.03 Million | 7.93 Million | 42.68 Million |
| Earnings Per Share Basic | -0.12 | -0.33 | - | -0.81 | 0.18 | 0.98 |
| Earnings Per Share Diluted | -0.12 | -0.33 | - | -0.81 | 0.18 | 0.98 |
| Weighted Average Shares Outstanding | 42.44 Million | 37.55 Million | 43.45 Million | 43.24 Million | 43.45 Million | 43.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.44 Million | 37.55 Million | 43.45 Million | 43.24 Million | 43.45 Million | 43.45 Million |
| Gross Margin | -0.01 | 0.02 | 0.08 | -0.02 | 0.08 | 0.18 |
| EBIT Margin | 0.02 | -0.07 | - | -0.11 | 0.03 | 0.12 |
| Profit Margin | -0.03 | -0.04 | 0.00 | -0.09 | 0.01 | 0.08 |
| EBITDA | 4.25 Million | -20.27 Million | - | -45.31 Million | 15.73 Million | 62.59 Million |
| Earnings Before Tax Margin | -0.15 | -0.08 | -0.00 | -0.12 | 0.02 | 0.11 |
FENC
CCNTF
601699
IVX
BRY
TSL